FDA Approves OXYCODONE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.

**FDA Approves ANDA for Lupin’s Oxycodone and Acetaminophen Combination Product** On February 24, 2017, the FDA approved Lupin Pharmaceuticals' Abbreviated New Drug Application for the opioid combination Oxycodone and Acetaminophen, opening a new low-cost pricing channel for a widely used pain management therapy amid intensifying generic competition in the market.